DNA (Ginkgo Bioworks Holdings) Accumulated Depreciation: $-197.6 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DNA Ginkgo Bioworks Holdings Inc DNA
60 GF Score
Price $6.53
GF Value $5.95
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Ginkgo Bioworks Holdings Accumulated Depreciation?

Ginkgo Bioworks Holdings DNA -5.64% 60 Accumulated Depreciation is $-197.6 Mil as of Jun. 2026. GuruFocus rates DNA with a GF Score™ of 60/100 and a GF Value™ of $5.95 (Fairly Valued). The stock has 5 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Ginkgo Bioworks Holdings's quarterly accumulated depreciation declined from Dec. 2025 ($-190.6 Mil) to Mar. 2026 ($-189.4 Mil) but then increased from Mar. 2026 ($-189.4 Mil) to Jun. 2026 ($-197.6 Mil).

Ginkgo Bioworks Holdings's annual accumulated depreciation increased from Dec. 2023 ($-120.7 Mil) to Dec. 2024 ($-160.9 Mil) and increased from Dec. 2024 ($-160.9 Mil) to Dec. 2025 ($-190.6 Mil).

Ginkgo Bioworks Holdings Accumulated Depreciation Related Terms

Ginkgo Bioworks Holdings Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Ginkgo Bioworks Holdings's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ginkgo Bioworks Holdings Accumulated Depreciation Chart

Ginkgo Bioworks Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial -61.05 -92.76 -120.72 -160.87 -190.60

Ginkgo Bioworks Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -173.50 -182.08 -190.60 -189.38 -197.58
DNA
60GF Score
Ginkgo Bioworks Holdings Inc DNA
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ginkgo Bioworks Holdings Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-197.6 Mil mean?
Ginkgo Bioworks Holdings (DNA) has a Accumulated Depreciation of $-197.6 Mil as of Jun. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Ginkgo Bioworks Holdings and its competitors.
Is Ginkgo Bioworks Holdings' Accumulated Depreciation too high?
Ginkgo Bioworks Holdings' current Accumulated Depreciation is $-197.6 Mil. Overall, Ginkgo Bioworks Holdings has a GF Score™ of 60/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ginkgo Bioworks Holdings' Accumulated Depreciation compare to RZLT and EIKN?
Ginkgo Bioworks Holdings' Accumulated Depreciation of $-197.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Biotechnology company?
A good Accumulated Depreciation depends on the Biotechnology industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Ginkgo Bioworks Holdings and its competitors. Ginkgo Bioworks Holdings's current Accumulated Depreciation is $-197.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginkgo Bioworks Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ginkgo Bioworks Holdings (DNA) is currently considered Fairly Valued. The stock's GF Value™ is $5.95, compared to a current price of $6.53 — trading 9.7% above its estimated fair value. The current Accumulated Depreciation is $-197.6 Mil. Ginkgo Bioworks Holdings' overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Ginkgo Bioworks Holdings (DNA), the current Accumulated Depreciation is $-197.6 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ginkgo Bioworks Holdings (DNA) Overvalued in 2026?

Based on GuruFocus' analysis, Ginkgo Bioworks Holdings stock appears to be overvalued. The current stock price of $6.53 is trading 9.7% above its estimated GF Value™ of $5.95. GuruFocus considers Ginkgo Bioworks Holdings to be Fairly Valued.

Key valuation signals for DNA:

  • Accumulated Depreciation: $-197.6 Mil
  • GF Value™: $5.95 vs. price of $6.53 (9.7% above fair value)
  • GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the DNA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ginkgo Bioworks Holdings Business Description

Other Exchanges DNA:Mexico
Address 27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
60GF Score

Get the complete analysis for DNA

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.53
Price
$5.95
GF Value